RUBICON Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RUBICON, and what generic and branded alternatives to RUBICON drugs are available?
RUBICON has sixty-one approved drugs.
There is one tentative approval on RUBICON drugs.
Drugs and US Patents for RUBICON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rubicon | OXCARBAZEPINE | oxcarbazepine | TABLET;ORAL | 077747-001 | Apr 9, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Rubicon | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 215101-001 | Aug 19, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Rubicon | CEVIMELINE HYDROCHLORIDE | cevimeline hydrochloride | CAPSULE;ORAL | 216682-001 | Apr 6, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Rubicon | DESVENLAFAXINE SUCCINATE | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 204028-003 | Dec 7, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Rubicon | PRIMIDONE | primidone | TABLET;ORAL | 214896-001 | Jun 28, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Rubicon | CARBIDOPA AND LEVODOPA | carbidopa; levodopa | TABLET;ORAL | 216505-002 | Sep 21, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.